Latest Insider Transactions at Eq Rx, Inc. (EQRX)
This section provides a real-time view of insider transactions for Eq Rx, Inc. (EQRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EQRx, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EQRx, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2023
|
Eli Casdin > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
48,187,042
-100.0%
|
-
|
|
Nov 09
2023
|
Melanie Nallicheri Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,851,147
-100.0%
|
-
|
|
Nov 09
2023
|
Melanie Nallicheri Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,306,246
-100.0%
|
-
|
|
Nov 09
2023
|
Melanie Nallicheri Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
626,999
+9.04%
|
$1,253,998
$2.21 P/Share
|
|
Nov 09
2023
|
Paul L Berns Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
627,000
-100.0%
|
-
|
|
Nov 09
2023
|
Jorge Conde Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
53,064,157
-100.0%
|
-
|
|
Nov 09
2023
|
Dina Ciarimboli General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
731,750
-100.0%
|
-
|
|
Nov 09
2023
|
Sandra Horning Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
470,250
-100.0%
|
-
|
|
Nov 09
2023
|
Alexis Borisy Executive Chairman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,810,000
-100.0%
|
-
|
|
Nov 09
2023
|
Ah Equity Partners Bio Ii, L.L.C. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
53,076,421
-100.0%
|
-
|
|
Nov 09
2023
|
Ah Equity Partners Lsv I, L.L.C. > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
53,076,421
-100.0%
|
-
|
|
Nov 09
2023
|
Amy Abernethy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
200,000
-100.0%
|
-
|
|
Jul 01
2023
|
Dina Ciarimboli General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
575,000
+44.0%
|
-
|
|
Dec 17
2021
|
Paul L Berns Director |
BUY
Grant, award, or other acquisition
|
Direct |
627,000
+50.0%
|
-
|
|
Dec 17
2021
|
Alexis Borisy Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
18,810,000
+50.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
BUY
Other acquisition or disposition
|
Direct |
200,000
+50.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
SELL
Other acquisition or disposition
|
Direct |
200,000
-100.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+50.0%
|
-
|
|
Dec 17
2021
|
Sandra Horning Director |
BUY
Grant, award, or other acquisition
|
Direct |
470,250
+50.0%
|
-
|
|
Dec 17
2021
|
Melanie Nallicheri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,851,147
+50.0%
|
-
|
|
Dec 17
2021
|
Melanie Nallicheri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,679,247
+50.0%
|
-
|
|
Dec 17
2021
|
Eric Hedrick Chief Physician Executive |
BUY
Grant, award, or other acquisition
|
Direct |
627,000
+50.0%
|
-
|
|
Dec 17
2021
|
Eli Casdin > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
39,527,671
+26.91%
|
$197,638,355
$5.0 P/Share
|
|
Dec 17
2021
|
Eli Casdin > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
8,659,372
+50.0%
|
-
|
|
Dec 17
2021
|
Jorge Conde Director |
BUY
Grant, award, or other acquisition
|
Indirect |
53,064,157
+50.0%
|
$530,641,570
$10.0 P/Share
|
|
Dec 17
2021
|
Jami Rubin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,194,500
+50.0%
|
-
|